Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Selpem1/Cya
Common Name:
Selp-KO
Product ID:
S-KO-04257
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Selp-KO
Strain ID
KOCMP-20344-Selp-B6J-VA
Gene Name
Selp
Product ID
S-KO-04257
Gene Alias
CD62P; GMP-140; Grmp; LECAM3; PADGEM
Background
C57BL/6JCya
NCBI ID
20344
Modification
Conventional knockout
Chromosome
1
Phenotype
MGI:98280
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Selpem1/Cya mice (Catalog S-KO-04257) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000162746
NCBI RefSeq
NM_011347
Target Region
Exon 2~7
Size of Effective Region
~9.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
SELP, which encodes P-selectin, is a cell adhesion molecule gene. P-selectin is expressed on activated endothelial cells and platelets and mediates rolling adhesion of leukocytes during inflammation [4]. It is involved in multiple biological processes such as inflammation, immune response, and thrombosis, and its expression and binding with its ligand PSGL-1 contribute to various pathophysiological mechanisms [3].

In a study on COVID-19, the homozygosity of SELP rs6127 (c.1807G > A; p.Asp603Asn) was associated with severe thrombosis in male patients, especially those over 50, as the gene is downregulated by testosterone [1]. In cervical cancer, elevated SELP expression in tumor endothelial cells was correlated with improved survival in radiotherapy-treated patients, with SELP + TECs interacting with CD8 + T cells via the ACKR1-CCL5 axis to enhance radiotherapy efficacy [2]. In sickle cell disease, P-selectin plays a role in the pathogenesis, and its inhibition has shown efficacy in mitigating vaso-occlusive events [3].

In summary, SELP is crucial in processes like inflammation, thrombosis, and anti-cancer immune response. Findings from human-based studies in COVID-19, cervical cancer, and sickle cell disease reveal its significance in disease-related biological processes, highlighting its potential as a therapeutic target.

References:

1. Fallerini, Chiara, Daga, Sergio, Benetti, Elisa, Renieri, Alessandra, Mari, Francesca. 2021. SELP Asp603Asn and severe thrombosis in COVID-19 males. In Journal of hematology & oncology, 14, 123. doi:10.1186/s13045-021-01136-9. https://pubmed.ncbi.nlm.nih.gov/34399825/

2. Huang, Qingyu, Yang, Wenhui, Wang, Fuhao, Hu, Qinyong, Liu, Chao. 2025. SELP+ TEC:CD8+ T cell crosstalk associates with improved radiotherapy efficacy in cervical cancer. In Molecular cancer, 24, 41. doi:10.1186/s12943-025-02244-7. https://pubmed.ncbi.nlm.nih.gov/39901166/

3. Gupta, Parul, Choudhari, Vaishali, Kumar, Ravindra. 2024. Exploring the genetic mechanisms: SELP gene's contribution to alleviating vaso-occlusive crisis in sickle cell disease. In Gene, 928, 148805. doi:10.1016/j.gene.2024.148805. https://pubmed.ncbi.nlm.nih.gov/39079562/

4. Zhang, Nan, Liu, Zhenghui, Yao, Longbiao, Mehta-D'souza, Padmaja, McEver, Rodger P. 2016. P-Selectin Expressed by a Human SELP Transgene Is Atherogenic in Apolipoprotein E-Deficient Mice. In Arteriosclerosis, thrombosis, and vascular biology, 36, 1114-21. doi:10.1161/ATVBAHA.116.307437. https://pubmed.ncbi.nlm.nih.gov/27102967/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest